Zurich Cantonal Bank
MRSN

Zurich Cantonal Bank’s Mersana Therapeutics MRSN Stock Holding History

Zurich Cantonal Bank’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-698
Closed -$22.2K – 2768
2023
Q3 		$22.2K Hold
698
– – ﹤0.01% 2700
2023
Q2 		$57.4K Buy
698
+208
+42% +$30.4K ﹤0.01% 2570
2023
Q1 		$50.3K Hold
490
– – ﹤0.01% 2594
2022
Q4 		$71.8K Buy
490
+200
+69% +$33.8K ﹤0.01% 2470
2022
Q3 		$49K Hold
290
– – ﹤0.01% 2598
2022
Q2 		$34K Hold
290
– – ﹤0.01% 2692
2022
Q1 		$29K Sell
290
-103
-26% -$12K ﹤0.01% 2616
2021
Q4 		$61K Sell
393
-11
-3% -$2.14K ﹤0.01% 2676
2021
Q3 		$95K Buy
404
+1
+0.2% +$292 ﹤0.01% 2371
2021
Q2 		$137K Buy
403
+5
+1% +$1.89K ﹤0.01% 2055
2021
Q1 		$161K Buy
398
+108
+37% +$52.4K ﹤0.01% 1904
2020
Q4 		$193K Buy
290
+63
+28% +$35K ﹤0.01% 1868
2020
Q3 		$106K Hold
227
– – ﹤0.01% 1956
2020
Q2 		$133K Buy
+227
New +$77.5K ﹤0.01% 1793

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return